In the previous version of the DSM (DSM-IV) 7, the classification listed ‘dependence’ rather than ‘use disorder’; with ‘moderate to severe’ SUD being regarded as equivalent to ‘dependence’. The International Classification of heroin addiction Diseases (ICD) 10th Revision (ICD-10) recognises ‘stimulant dependence syndrome’ and ‘stimulant withdrawal state’ 8. However, neither diagnostic tool differentiates between AMPH/MA and other non-cocaine stimulant SUDs; while the 11th Revision of the ICD narrows the definition to “stimulant dependence including amphetamines, methamphetamine or methcathinone” 9.
The Process of Amphetamine Addiction Treatment
We reviewed pexacerfont in one study, a 3-week trial of 51 Iranian men within residential treatment camps where treatment is not normally provided 52. Dosing was tapered from 300 mg po OD for the first week, to 200 mg po OD in Week 2 and 100 mg po OD in Week 3. While measures of craving reduced significantly more in the treatment arm than placebo, there was no difference in end-of-treatment abstinence between groups. Additionally, levels of temptation and depression, but not anxiety, withdrawal severity, or treatment effectiveness, improved favouring treatment. Of the 4065 participants reported on in the reviewed studies, 2858 (70.3%) were male. Nine of the 43 studies (21%) enrolled only males 24, 29, 30, 34, 46, 52, 55, 57, 58, however not all of these were by design.
- Therefore, optimising therapeutic efficacy whilst simultaneously maintaining side effects at an acceptable level is a difficult balance requiring careful dose titration in the patient.
- These stimulants are commonly prescribed to treat conditions such as obesity, ADHD, narcolepsy, and binge-eating disorder.
- Amphetamine is in a class of medications called central nervous system stimulants.
clinical Criteria
In total, 55 primary outcome measures were used (inclusive of variations) 93 times (as some studies had multiple primary outcomes). The most common primary outcome measure reported was abstinence (51 times, 55%), followed by cravings (10 times, 11%). For abstinence, urine drug screens (UDS) were used 41 times (80%) and analysed or defined in 16 different ways. The most common method for analysing UDS was weekly proportion of AMPH/MA-free UDS, or overall proportion of AMPH/MA-free UDS. There were 75 distinct secondary outcomes inclusive of variations and often analysed differently to the primary outcomes of the same domain.
The pharmacology of amphetamine
- Your doctor may decide not to treat you with this medication or change some of the other medicines you take.
- ICD code F15.20 is used to classify a diagnosis of uncomplicated dependence on other stimulants in medical records and documentation.
- Other substance use and social environments will also feature when determining the best setting for clinical care 75.
- Amphetamine users may also use other drugs inappropriately to manage the side effects of amphetamines.
The 43 studies examined 23 individual pharmacotherapies, most individually and some in combination. Table 3 lists the pharmacotherapies reviewed, and the proposed mechanisms of action related to their use in studies of MA/AMPH dependence. We approached this report as a systematic review of the peer-reviewed literature, Amphetamine Addiction and present the methods and results in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement 22. Additionally, behavioral therapy techniques, such as cognitive-behavioral therapy (CBT), can help individuals identify and modify the thought patterns and behaviors that contribute to their addiction. Addiction is a complex disease that affects the brain’s reward system and leads to compulsive drug-seeking behavior.
Symptoms of amphetamine addiction
The study systematically reviewed the effectiveness of pharmacological treatments alone or combined with brief cognitive-behavioural therapy (BCBT) for treating Iranian amphetamine abusers. The secondary aim was to review the efficacy of BCBT alone or combined with pharmacological treatments for treating amphetamine abusers in the world. No study we reviewed directly compared outcomes between outpatient- and inpatient-treated participants. Importantly, we did not find any evidence that either treatment setting is superior to another for any of the outcomes we assessed.
Amphetamines include the drug amphetamine and its many variants such as methamphetamine (speed or crystal meth) and methylenedioxymethamphetamine (MDMA, Ecstasy, or Adam). Methamphetamine is the most commonly used amphetamine in the United States. Amphetamines are usually taken by mouth but can be snorted, smoked, or injected. Amphetamines produce dopamine, the neurotransmitter that causes happiness and euphoria, and feelings of reward and pleasure in the limbic reward system of the brain. This artificial production of dopamine is highly addictive and causes many to become hooked on abusing amphetamines. Keep a written list of all of the prescription and nonprescription (over-the-counter) medicines, vitamins, minerals, and dietary supplements you are taking.